Fetal Lung Hypoplasia: Biochemical and Structural Variations and Their Possible Significance
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Lung Pathology: Embryologic Abnormalities
Chapter2C Lung Pathology: Embryologic Abnormalities Content and Objectives Pulmonary Sequestration 2C-3 Chest X-ray Findings in Arteriovenous Malformation of the Great Vein of Galen 2C-7 Situs Inversus Totalis 2C-10 Congenital Cystic Adenomatoid Malformation of the Lung 2C-14 VATER Association 2C-20 Extralobar Sequestration with Congenital Diaphragmatic Hernia: A Complicated Case Study 2C-24 Congenital Chylothorax: A Case Study 2C-37 Continuing Nursing Education Test CNE-1 Objectives: 1. Explain how the diagnosis of pulmonary sequestration is made. 2. Discuss the types of imaging studies used to diagnose AVM of the great vein of Galen. 3. Describe how imaging studies are used to treat AVM. 4. Explain how situs inversus totalis is diagnosed. 5. Discuss the differential diagnosis of congenital cystic adenomatoid malformation. (continued) Neonatal Radiology Basics Lung Pathology: Embryologic Abnormalities 2C-1 6. Describe the diagnosis work-up for VATER association. 7. Explain the three classifications of pulmonary sequestration. 8. Discuss the diagnostic procedures for congenital chylothorax. 2C-2 Lung Pathology: Embryologic Abnormalities Neonatal Radiology Basics Chapter2C Lung Pathology: Embryologic Abnormalities EDITOR Carol Trotter, PhD, RN, NNP-BC Pulmonary Sequestration pulmonary sequestrations is cited as the 1902 theory of Eppinger and Schauenstein.4 The two postulated an accessory he clinician frequently cares for infants who present foregut tracheobronchia budding distal to the normal buds, Twith respiratory distress and/or abnormal chest x-ray with caudal migration giving rise to the sequestered tissue. The findings of undetermined etiology. One of the essential com- type of sequestration, intralobar or extralobar, would depend ponents in the process of patient evaluation is consideration on the timing of the accessory foregut budding (Figure 2C-1). -
427 © Springer Nature Switzerland AG 2020 R. H. Cleveland, E. Y. Lee
Index A Arterial hypertensive vasculopathy ABCA3 deficiency, 158 imaging features, 194 pathological features, 194 Aberrant coronary artery, 22 Aspergillosis, 413 Acinar dysplasia, 147–150 Aspergillus, 190, 369, 414 Acquired bronchobiliary fistula (aBBF), 79, 80 Aspergillus fumigatus, 110, 358, 359 Acquired immunodeficiency, 191, 192 Aspergillus-related lung disease, 413 Aspiration pneumonia, 136 Acrocyanosis, 1 Aspiration syndromes, 248 Actinomycosis, 109, 110 causes, 172 Acute cellular rejection (ACR), 192, 368 imaging features, 172 Acute eosinophilic pneumonia, 172 pathological features, 172 Acute infectious disease Associated with pulmonary arterial hypertension (APAH), 257 imaging features, 167 Asthma pathological features, 167 ABPA, 343 Acute interstitial pneumonia (AIP), 146, 173, 176 airway biopsy, 339 imaging features, 176 airway edema, 337 pathological features, 176 airway hyperresponsiveness, 337 symptoms, 176 airway inflammation, 337 Acute Langerhans cell histiocytosis (LCH), 185 allergy testing, 339 Acute pulmonary embolism, 386, 387 anxiety and depression, 344 complications, 388 API, 339 mortality rates, 388 biodiversity hypothesis, 337 pre-operative management, 387 bronchial challenge tests, 338 technique, 387, 388 bronchoconstriction, 337 treatment, 387 bronchoscopy, 339 Acute rejection, 192 clinical manifestations, 337 Adenoid cystic carcinoma, 306, 307 clinical presentation, 338 Adenotonsillar hypertrophy, 211 comorbid conditions, 342, 343 Air bronchograms, 104 definition, 337 Air leak syndromes, 53, 55 diagnosis, 338–340, -
Hyperplasia (Growth Factors
Adaptations Robbins Basic Pathology Robbins Basic Pathology Robbins Basic Pathology Coagulation Robbins Basic Pathology Robbins Basic Pathology Homeostasis • Maintenance of a steady state Adaptations • Reversible functional and structural responses to physiologic stress and some pathogenic stimuli • New altered “steady state” is achieved Adaptive responses • Hypertrophy • Altered demand (muscle . hyper = above, more activity) . trophe = nourishment, food • Altered stimulation • Hyperplasia (growth factors, . plastein = (v.) to form, to shape; hormones) (n.) growth, development • Altered nutrition • Dysplasia (including gas exchange) . dys = bad or disordered • Metaplasia . meta = change or beyond • Hypoplasia . hypo = below, less • Atrophy, Aplasia, Agenesis . a = without . nourishment, form, begining Robbins Basic Pathology Cell death, the end result of progressive cell injury, is one of the most crucial events in the evolution of disease in any tissue or organ. It results from diverse causes, including ischemia (reduced blood flow), infection, and toxins. Cell death is also a normal and essential process in embryogenesis, the development of organs, and the maintenance of homeostasis. Two principal pathways of cell death, necrosis and apoptosis. Nutrient deprivation triggers an adaptive cellular response called autophagy that may also culminate in cell death. Adaptations • Hypertrophy • Hyperplasia • Atrophy • Metaplasia HYPERTROPHY Hypertrophy refers to an increase in the size of cells, resulting in an increase in the size of the organ No new cells, just larger cells. The increased size of the cells is due to the synthesis of more structural components of the cells usually proteins. Cells capable of division may respond to stress by undergoing both hyperrtophy and hyperplasia Non-dividing cell increased tissue mass is due to hypertrophy. -
Reportable BD Tables Apr2019.Pdf
April 2019 Georgia Department of Public Health | Division of Health Protection | Maternal and Child Health Epidemiology Unit Reportable Birth Defects with ICD-10-CM Codes Reportable Birth Defects in Georgia with ICD-10-CM Diagnosis Codes Table D.1 Brain Malformations and Neural Tube Defects ICD-10-CM Diagnosis Codes Birth Defect ICD-10-CM 1. Brain Malformations and Neural Tube Defects Q00-Q05, Q07 Anencephaly Q00.0 Craniorachischisis Q00.1 Iniencephaly Q00.2 Frontal encephalocele Q01.0 Nasofrontal encephalocele Q01.1 Occipital encephalocele Q01.2 Encephalocele of other sites Q01.8 Encephalocele, unspecified Q01.9 Microcephaly Q02 Malformations of aqueduct of Sylvius Q03.0 Atresia of foramina of Magendie and Luschka (including Dandy-Walker) Q03.1 Other congenital hydrocephalus (including obstructive hydrocephaly) Q03.8 Congenital hydrocephalus, unspecified Q03.9 Congenital malformations of corpus callosum Q04.0 Arhinencephaly Q04.1 Holoprosencephaly Q04.2 Other reduction deformities of brain Q04.3 Septo-optic dysplasia of brain Q04.4 Congenital cerebral cyst (porencephaly, schizencephaly) Q04.6 Other specified congenital malformations of brain (including ventriculomegaly) Q04.8 Congenital malformation of brain, unspecified Q04.9 Cervical spina bifida with hydrocephalus Q05.0 Thoracic spina bifida with hydrocephalus Q05.1 Lumbar spina bifida with hydrocephalus Q05.2 Sacral spina bifida with hydrocephalus Q05.3 Unspecified spina bifida with hydrocephalus Q05.4 Cervical spina bifida without hydrocephalus Q05.5 Thoracic spina bifida without -
Surfactant Abnormalities in ALTE and SIDS Arch Dis Child: First Published As 10.1136/Adc.71.6.501 on 1 December 1994
Archives ofDisease in Childhood 1994; 71: 501-505 501 Surfactant abnormalities in ALTE and SIDS Arch Dis Child: first published as 10.1136/adc.71.6.501 on 1 December 1994. Downloaded from I B Masters, J Vance, B A Hills Abstract mechanical stability of the distal airspaces.2 Abnormalities in the relative concentra- Reduced concentrations of surfactant, in tions ofthe components ofsurfactant have particular disaturated phosphatidylcholine been implicated in prolonged expiratory (DPPC) have been described in infants apnoea (PEA) and sudden infant death with PEA and SIDS.3-9 Southall et al have syndrome (SIDS). Controversy has, implicated low concentrations of DPPC and however, surrounded these findings, as postulated lung mechanic, neurosensory, and they may be secondary to terminal pulmonary vascular mechanisms for these life events. In this study the physical events.5 6 properties of surfactant were measured in Previously we have shown that both an children with recurrent apparent life infant and young child with prolonged threatening events (ALTEs), PEA, and expiratory apnoea had significant quantitative SIDS. Bronchial lavage samples were and qualitative abnormalities in their obtained from 21 children with recurrent surfactant.'I These findings were similar to the ALTEs, two SIDS victims, and 26 control low concentrations of DPPC found in other patients. Lipid components were immedi- studies.2-5 The reliability of such findings, ately elutriated from these samples however, is questionable in both those and with liquid chloroform. The physical our own observations, as the ability to extract properties of the extracted surfactant surfactant with lung washings in a standardised were studied on a Langmuir trough in fashion from the living subject's lung is which the area (A) of the monolayer was difficult. -
Chapter 1 Cellular Reaction to Injury 3
Schneider_CH01-001-016.qxd 5/1/08 10:52 AM Page 1 chapter Cellular Reaction 1 to Injury I. ADAPTATION TO ENVIRONMENTAL STRESS A. Hypertrophy 1. Hypertrophy is an increase in the size of an organ or tissue due to an increase in the size of cells. 2. Other characteristics include an increase in protein synthesis and an increase in the size or number of intracellular organelles. 3. A cellular adaptation to increased workload results in hypertrophy, as exemplified by the increase in skeletal muscle mass associated with exercise and the enlargement of the left ventricle in hypertensive heart disease. B. Hyperplasia 1. Hyperplasia is an increase in the size of an organ or tissue caused by an increase in the number of cells. 2. It is exemplified by glandular proliferation in the breast during pregnancy. 3. In some cases, hyperplasia occurs together with hypertrophy. During pregnancy, uterine enlargement is caused by both hypertrophy and hyperplasia of the smooth muscle cells in the uterus. C. Aplasia 1. Aplasia is a failure of cell production. 2. During fetal development, aplasia results in agenesis, or absence of an organ due to failure of production. 3. Later in life, it can be caused by permanent loss of precursor cells in proliferative tissues, such as the bone marrow. D. Hypoplasia 1. Hypoplasia is a decrease in cell production that is less extreme than in aplasia. 2. It is seen in the partial lack of growth and maturation of gonadal structures in Turner syndrome and Klinefelter syndrome. E. Atrophy 1. Atrophy is a decrease in the size of an organ or tissue and results from a decrease in the mass of preexisting cells (Figure 1-1). -
CELL INJURY MEDICAL (Lecture 1)
CELL INJURY MEDICAL (lecture 1) Sufia Husain Assistant Prof & Consultant College of Medicine, KSU, Riyadh. September 2015 Objectives for Cell Injury Chapter (3 lectures) The students should: A. Understand the concept of cells and tissue adaptation to environmental stress including the meaning of hypertrophy, hyperplasia, aplasia, atrophy, hypoplasia and metaplasia with their clinical manifestations. B. Is aware of the concept of hypoxic cell injury and its major causes. C. Understand the definitions and mechanisms of free radical injury. D. Knows the definition of apoptosis, tissue necrosis and its various types with clinical examples. E. Able to differentiate between necrosis and apoptosis. F. Understand the causes of and pathologic changes occurring in fatty change (steatosis), accumulations of exogenous and endogenous pigments (carbon, silica, iron, melanin, bilirubin and lipofuscin). G. Understand the causes of and differences between dystrophic and metastatic calcifications. Lecture 1 outline . Adaptation to environmental stress: hypertrophy, hyperplasia, aplasia, hypoplasia, atrophy, squamous metaplasia, osseous metaplasia and myeloid metaplasia. Hypoxic cell injury and its causes (ischaemia, anaemia, carbon monoxide poisoning, decreased perfusion of tissues by oxygen, carrying blood and poor oxygenation of blood). Free radical injury: definition of free radicals, mechanisms that generate free radicals, mechanisms that degrade free radicals. Reversible and irreversible cell injury ADAPTATION TO ENVIRONMENTAL STRESS Adaptation to environmental stress . Cells are constantly adjusting their structure and function to accommodate changing demands i.e. they adapt within physiological limits. As cells encounter physiologic stresses or pathologic stimuli, they can undergo adaptation. The principal adaptive responses are . hypertrophy, . hyperplasia, . atrophy, . metaplasia. (NOTE: If the adaptive capability is exceeded or if the external stress is harmful, cell injury develops. -
Adult Outcome of Congenital Lower Respiratory Tract Malformations M S Zach, E Eber
500 Arch Dis Child: first published as 10.1136/adc.87.6.500 on 1 December 2002. Downloaded from PAEDIATRIC ORIGINS OF ADULT LUNG DISEASES Series editors: P Sly, S Stick Adult outcome of congenital lower respiratory tract malformations M S Zach, E Eber ............................................................................................................................. Arch Dis Child 2002;87:500–505 ongenital malformations of the lower respiratory tract relevant studies have shown absence of the normal peristaltic are usually diagnosed and managed in the newborn wave, atonia, and pooling of oesophageal contents.89 Cperiod, in infancy, or in childhood. To what extent The clinical course in the first years after repair of TOF is should the adult pulmonologist be experienced in this often characterised by a high incidence of chronic respiratory predominantly paediatric field? symptoms.910 The most typical of these is a brassy, seal-like There are three ways in which an adult physician may be cough that stems from the residual tracheomalacia. While this confronted with this spectrum of disorders. The most frequent “TOF cough” is both impressive and harmless per se, recurrent type of encounter will be a former paediatric patient, now bronchitis and pneumonitis are also frequently observed.711In reaching adulthood, with the history of a surgically treated rare cases, however, tracheomalacia can be severe enough to respiratory malformation; in some of these patients the early cause life threatening apnoeic spells.712 These respiratory loss of lung tissue raises questions of residual damage and symptoms tend to decrease in both frequency and severity compensatory growth. Secondly, there is an increasing with age, and most patients have few or no respiratory number of children in whom paediatric pulmonologists treat complaints by the time they reach adulthood.13 14 respiratory malformations expectantly; these patients eventu- The entire spectrum of residual respiratory morbidity after ally become adults with their malformation still in place. -
(12) Patent Application Publication (10) Pub. No.: US 2010/0210567 A1 Bevec (43) Pub
US 2010O2.10567A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0210567 A1 Bevec (43) Pub. Date: Aug. 19, 2010 (54) USE OF ATUFTSINASATHERAPEUTIC Publication Classification AGENT (51) Int. Cl. A638/07 (2006.01) (76) Inventor: Dorian Bevec, Germering (DE) C07K 5/103 (2006.01) A6IP35/00 (2006.01) Correspondence Address: A6IPL/I6 (2006.01) WINSTEAD PC A6IP3L/20 (2006.01) i. 2O1 US (52) U.S. Cl. ........................................... 514/18: 530/330 9 (US) (57) ABSTRACT (21) Appl. No.: 12/677,311 The present invention is directed to the use of the peptide compound Thr-Lys-Pro-Arg-OH as a therapeutic agent for (22) PCT Filed: Sep. 9, 2008 the prophylaxis and/or treatment of cancer, autoimmune dis eases, fibrotic diseases, inflammatory diseases, neurodegen (86). PCT No.: PCT/EP2008/007470 erative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the S371 (c)(1), present invention relates to pharmaceutical compositions (2), (4) Date: Mar. 10, 2010 preferably inform of a lyophilisate or liquid buffersolution or artificial mother milk formulation or mother milk substitute (30) Foreign Application Priority Data containing the peptide Thr-Lys-Pro-Arg-OH optionally together with at least one pharmaceutically acceptable car Sep. 11, 2007 (EP) .................................. O7017754.8 rier, cryoprotectant, lyoprotectant, excipient and/or diluent. US 2010/0210567 A1 Aug. 19, 2010 USE OF ATUFTSNASATHERAPEUTIC ment of Hepatitis BVirus infection, diseases caused by Hepa AGENT titis B Virus infection, acute hepatitis, chronic hepatitis, full minant liver failure, liver cirrhosis, cancer associated with Hepatitis B Virus infection. 0001. The present invention is directed to the use of the Cancer, Tumors, Proliferative Diseases, Malignancies and peptide compound Thr-Lys-Pro-Arg-OH (Tuftsin) as a thera their Metastases peutic agent for the prophylaxis and/or treatment of cancer, 0008. -
Complete Androgen Insensitivity Syndrome in a Chinese Neonate
HK J Paediatr (new series) 2004;9:248-252 Complete Androgen Insensitivity Syndrome in a Chinese Neonate MC HO, KL NG Abstract Complete androgen insensitivity syndrome (CAIS) is a rare X-linked disorder with a female external phenotype.1 We report on a Chinese baby with CAIS who presented with bilateral inguinal hernias. The baby has a normal female phenotype at birth. On further evaluation, the karyotype was found to be 46, XY. Endocrine findings were compatible with androgen insensitivity syndrome. Bilateral herniotomy was performed. We would review the literature, offer an overview of the disease, and discuss the outcome with emphasis on the treatment modalities. Key words Complete androgen insensitivity; Male pseudohermaphrodites Introduction investigations which, to the best of our knowledge, has not been reported on the literature.4 Herein we report a case of In 1953, an American gynaecologist JM Morris firstly CAIS in a Chinese neonate in the local region. described a series of individuals with androgen insensitivity syndrome (AIS).2 He reported that these individuals had normal female external genitalia, normal female breast Case Report development, absent or scant axillary and pubic hair, absent internal genital organs and undescended testes. AIS is the The patient was a Chinese baby born at full term by most common condition that results in male under- spontaneous vaginal delivery weighing 2.67 Kg. The masculinisation.3 It is caused by mutations in the androgen antenatal and postnatal course was uneventful. She was the receptor (AR) gene and encompasses a wide spectrum of first child born to the parents. There was no consanguinity male pseudohermaphroditisms.2 In complete androgen nor any significant family history, in particular there was insensitivity syndrome (CAIS), the function of the AR is no abnormal puberty nor infertility on the maternal side. -
Appendix 3.1 Birth Defects Descriptions for NBDPN Core, Recommended, and Extended Conditions Updated March 2017
Appendix 3.1 Birth Defects Descriptions for NBDPN Core, Recommended, and Extended Conditions Updated March 2017 Participating members of the Birth Defects Definitions Group: Lorenzo Botto (UT) John Carey (UT) Cynthia Cassell (CDC) Tiffany Colarusso (CDC) Janet Cragan (CDC) Marcia Feldkamp (UT) Jamie Frias (CDC) Angela Lin (MA) Cara Mai (CDC) Richard Olney (CDC) Carol Stanton (CO) Csaba Siffel (GA) Table of Contents LIST OF BIRTH DEFECTS ................................................................................................................................................. I DETAILED DESCRIPTIONS OF BIRTH DEFECTS ...................................................................................................... 1 FORMAT FOR BIRTH DEFECT DESCRIPTIONS ................................................................................................................................. 1 CENTRAL NERVOUS SYSTEM ....................................................................................................................................... 2 ANENCEPHALY ........................................................................................................................................................................ 2 ENCEPHALOCELE ..................................................................................................................................................................... 3 HOLOPROSENCEPHALY............................................................................................................................................................. -
Respiratory Distress in the Newborn
Respiratory Distress in the Newborn Suzanne Reuter, MD,* Chuanpit Moser, MD,† Michelle Baack, MD*‡ *Department of Neonatal-Perinatal Medicine, Sanford School of Medicine–University of South Dakota, Sanford Children’s Specialty Clinic, Sioux Falls, SD. †Department of Pediatric Pulmonology, Sanford School of Medicine–University of South Dakota, Sanford Children’s Specialty Clinic, Sioux Falls, SD. ‡Sanford Children’s Health Research Center, Sioux Falls, SD. Educational Gap Respiratory distress is common, affecting up to 7% of all term newborns, (1) and is increasingly common in even modest prematurity. Preventive and therapeutic measures for some of the most common underlying causes are well studied and when implemented can reduce the burden of disease. (2)(3)(4)(5)(6)(7)(8) Failure to readily recognize symptoms and treat the underlying cause of respiratory distress in the newborn can lead to short- and long-term complications, including chronic lung disease, respiratory failure, and even death. Objectives After completing this article, the reader should be able to: 1. Use a physiologic approach to understand and differentially diagnose the most common causes of respiratory distress in the newborn infant. 2. Distinguish pulmonary disease from airway, cardiovascular, and other systemic causes of respiratory distress in the newborn. 3. Appreciate the risks associated with late preterm (34–36 weeks’ gestation) and early term (37–38 weeks’ gestation) deliveries, especially AUTHOR DISCLOSURES Drs Reuter, Moser, by caesarean section. and Baack have disclosed no financial 4. Recognize clinical symptoms and radiographic patterns that reflect relationships relevant to this article. This commentary does not contain information transient tachypnea of the newborn (TTN), neonatal pneumonia, about unapproved/investigative commercial respiratory distress syndrome (RDS), and meconium aspiration products or devices.